These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3359477)

  • 21. [About the antimicrobial activity of substituted aromatic aldehydes (author's transl)].
    Rehn D; Nolte H; Zerling W
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 172(6):508-19. PubMed ID: 7257654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of chlorated oxyquinoline derivatives on anaerobic microorganisms].
    Ellenrieder M; Sensch KH
    Arzneimittelforschung; 1972 May; 22(5):908-9. PubMed ID: 5068208
    [No Abstract]   [Full Text] [Related]  

  • 23. [Gentamycin and its drug forms].
    Nazarov AD; Sinitsyna NI; Toroptseva ON; Kagan EE
    Antibiotiki; 1983 May; 28(5):366-76. PubMed ID: 6349519
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rifamycin].
    Acocella G
    G Ital Chemioter; 1983; 30(1):1-24. PubMed ID: 6363192
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro activity of cefotaxime (HR 756) and 21 other antibiotics on 329 hospital strains].
    Marcenac FM; Fernández AJ; Rebollo MN; Herrán IL; de Berdaguer RF
    Medicina (B Aires); 1980; 40(4):397-406. PubMed ID: 6259490
    [No Abstract]   [Full Text] [Related]  

  • 26. Rifampicin.
    Polascik M; Golden B
    Ann Ophthalmol; 1971 Aug; 3(8):877-82. PubMed ID: 5005929
    [No Abstract]   [Full Text] [Related]  

  • 27. [In vitro activity and resistance of 4-quinolones].
    Bauernfeind A
    Infection; 1986; 14 Suppl 3():S186-7. PubMed ID: 3531027
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and antimicrobial activities of some new pyrrolylthieno[2,3-b]-quinoline derivatives.
    Geies AA; Bakhite EA; el-Kashef HS
    Pharmazie; 1998 Oct; 53(10):686-90. PubMed ID: 9812334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Broad-spectrum quinolones (2d-generation quinolones)].
    Neuman M
    Therapie; 1986; 41(2):123-8. PubMed ID: 3726784
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the chemistry and biochemical mechanism of action of streptomycin].
    Schmidt H; Sych FJ; Gosda W
    Pharmazie; 1968 Apr; 23(4):161-73. PubMed ID: 4176185
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
    Zemelman R; González C; Mondaca MA
    Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibiotic sensitivity and the chemical structures of the bacterial wall].
    Shoshiev LN; Orlova GM; Makarovskaia LN
    Antibiotiki; 1980 Jun; 25(6):468-74. PubMed ID: 6994633
    [No Abstract]   [Full Text] [Related]  

  • 34. [Desulfurization of 7-aminodeacetoxycephalosporanic acid].
    Hirose T; Chiba K; Mishio S; Nakano J; Uno H
    Yakugaku Zasshi; 1984 Mar; 104(3):302-7. PubMed ID: 6470937
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibiotics and chemotherapeutic agents--from research to practice. II. Remarks for the practitioner on the characteristics of tetracyclines].
    Pilloud M
    Schweiz Arch Tierheilkd; 1982 Apr; 124(4):179-88. PubMed ID: 7048522
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibiotics and chemotherapeutic agents--from research to practice. X. Various comments intended for practitioners on the properties of cephalosporins].
    Pilloud M
    Schweiz Arch Tierheilkd; 1984 Apr; 126(4):173-87. PubMed ID: 6374890
    [No Abstract]   [Full Text] [Related]  

  • 37. [In-vitro nitroxyquinoline sensitivity of microorganisms cultured from urine specimens of patients with urinary tract infections].
    Hatala M; Hnátek J; Uhlír O; Marková Z
    Cas Lek Cesk; 1973; 112(23):718-22. PubMed ID: 4716471
    [No Abstract]   [Full Text] [Related]  

  • 38. [Quinolones--increased possibilities of antibacterial therapy].
    Novácek L
    Cas Lek Cesk; 1988 Feb; 127(6):184-7. PubMed ID: 3359477
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fluoroquinolones. 1. Their chemical structure, mechanism of action and antibacterial activity].
    Stahlmann R; Kemmerich B; Lode H
    Dtsch Med Wochenschr; 1988 Apr; 113(16):648-51. PubMed ID: 2834166
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fluoroquinolones].
    Baykal M; Akalin E
    Mikrobiyol Bul; 1987 Apr; 21(2):151-7. PubMed ID: 3482120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.